We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Taiwan Liposome Company Ltd | NASDAQ:TLC | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.00 | 6.66 | 7.10 | 0 | 01:00:00 |
OMB APPROVAL | ||||||
OMB Number: | 3235-0167 | |||||
Expires: | July 31, 2024 | |||||
Estimated average burden | ||||||
hours per response | 1.50 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-38746
Woods Investment Company, Ltd.**
(Exact name of registrant as specified in its charter)
11F-1, No. 3, Park Street, Nangang District, Taipei, Taiwan
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Shares, no par value
Special Shares, no par value
(Title of each class of securities covered by this Form)
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) |
☒ | |
Rule 12g-4(a)(2) |
☐ | |
Rule 12h-3(b)(1)(i) |
☒ | |
Rule 12h-3(b)(1)(ii) |
☐ | |
Rule 15d-6n |
☐ | |
Rule 15d-22(b) |
☐ |
Approximate number of holders of record as of the certification or notice date: No record holder of Special Shares; One record holder of Common Shares
Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: | January 27, 2022 | By: |
/s/ George Yeh |
|||
Name: George Yeh | ||||||
Title: Director |
Instruction: This form is required by Rules 12g-4, 12h-3, 15d-6 and 15d-22 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.
SEC 2069 (08-11) | Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 |
Woods Investment Company, Ltd. became the successor registrant to Taiwan Liposome Company, Ltd. in connection with a share swap transaction between the two companies on October 12, 2021. Under Rule 12g-3(a), series B-1 special shares of the Registrant (the Special Shares) and the common shares of the Issuer into which the Special Shares are convertible (the Common Shares) were deemed to be registered under Section 12(g) of the Exchange Act. All of the Special Shares had been converted into Common Shares as of November 11, 2021. The number of record holders of the Special Shares was reduced recently to less than 300 persons. |
1 Year Taiwan Liposome Chart |
1 Month Taiwan Liposome Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions